Geode Capital Management’s Jasper Therapeutics JSPR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $728K | Sell |
131,130
-132,554
| -50% | -$736K | ﹤0.01% | 3431 |
|
2025
Q1 | $1.13M | Buy |
263,684
+5,997
| +2% | +$25.8K | ﹤0.01% | 3261 |
|
2024
Q4 | $5.51M | Buy |
257,687
+271
| +0.1% | +$5.8K | ﹤0.01% | 2697 |
|
2024
Q3 | $4.84M | Sell |
257,416
-2,338
| -0.9% | -$44K | ﹤0.01% | 2774 |
|
2024
Q2 | $5.9M | Buy |
259,754
+131,763
| +103% | +$2.99M | ﹤0.01% | 2634 |
|
2024
Q1 | $3.76M | Sell |
127,991
-776,486
| -86% | -$22.8M | ﹤0.01% | 2855 |
|
2023
Q4 | $714K | Hold |
904,477
| – | – | ﹤0.01% | 3475 |
|
2023
Q3 | $633K | Sell |
904,477
-61,027
| -6% | -$42.7K | ﹤0.01% | 3511 |
|
2023
Q2 | $1.32M | Sell |
965,504
-104,810
| -10% | -$144K | ﹤0.01% | 3249 |
|
2023
Q1 | $1.94M | Buy |
1,070,314
+942,898
| +740% | +$1.71M | ﹤0.01% | 3044 |
|
2022
Q4 | $60K | Sell |
127,416
-318
| -0.2% | -$150 | ﹤0.01% | 4542 |
|
2022
Q3 | $100K | Hold |
127,734
| – | – | ﹤0.01% | 4578 |
|
2022
Q2 | $246K | Hold |
127,734
| – | – | ﹤0.01% | 4139 |
|
2022
Q1 | $453K | Buy |
127,734
+10,684
| +9% | +$37.9K | ﹤0.01% | 3980 |
|
2021
Q4 | $918K | Buy |
+117,050
| New | +$918K | ﹤0.01% | 3763 |
|
2021
Q1 | – | Sell |
-25,627
| Closed | -$258K | – | 4458 |
|
2020
Q4 | $258K | Sell |
25,627
-7,873
| -24% | -$79.3K | ﹤0.01% | 3805 |
|
2020
Q3 | $331K | Hold |
33,500
| – | – | ﹤0.01% | 3567 |
|
2020
Q2 | $335K | Hold |
33,500
| – | – | ﹤0.01% | 3503 |
|
2020
Q1 | $319K | Buy |
+33,500
| New | +$319K | ﹤0.01% | 3409 |
|